Dataset Information

Gene expression profiles of FGF-treated prostate cancer cells

ABSTRACT: Fibroblast growth factor 23 (FGF23) is a member of endocrine FGF subfamily, which includes FGF19, FGF21 and FGF23. We explored the question of whether different FGF ligands are activating the same transcriptional program in prostate cancer (PCa) cells or whether there are unique or partially overlapping activities as well.

ORGANISM(S): Homo sapiens

PROVIDER: GSE62192 | GEO | 2015/05/29

SECONDARY ACCESSION(S): PRJNA263407

REPOSITORIES: GEO

ACCESS DATA

Shared Molecules

Only show the datasets with similarity scores above: 0.5

Threshold

0.5

Similar Datasets

Project description:Cell signaling molecules are essential drivers of gene expression patterns, which are crucial for the development of multicellular organisms. Although prior research has established the importance of the levels and distribution of these molecules for gene expression patterns during embryonic development, a complete understanding of the specific targets influenced by their activity remains elusive. This study investigates how the fibroblast growth factor (FGF), a key developmental signal, orchestrates gene expression during the organogenesis of the zebrafish lateral line. Our analysis provides a detailed catalog of genes mediated by FGF signaling and identified dose-dependent genes that consistently respond to varying levels of extracellular FGF signaling in vivo. Notably, we uncovered an unexpected group of target genes that show suppressed expression at increased levels of FGF ligand, independent of changes in extracellular signaling. Experiments utilizing mosaic mis-expression of FGF ligands demonstrate that this gene regulation occurs autonomously within individual cells. In embryos with endogenous FGF levels, these target genes are suppressed in FGF-producing cells that shows nuclear accumulation of the FGF ligand. Targeted degradation of nuclear FGF confirms its role in this suppression, while not interfering with the activity of extracellular FGF signaling in the neighboring cells. Thus, we propose a novel mechanism of gene expression patterning in which the FGF ligand is directed to the nucleus within source cells. This process autonomously regulates its signaling targets, which are induced by extracellular FGF, leading to a self-organized symmetry-breaking in FGF signaling targets. Our findings of consistent gene expression patterns across multiple tissues, together with the nuclear localization of other paracrine FGF ligands, indicate that the cell-autonomous gene regulation by nuclear-targeted ligands could be a more widespread mechanism.

Project description:We used gene array analysis of cortical bone to identify Phex-dependent gene transcripts regulating Fgf23 production and mineralization in Hyp mice. We discovered that activation of Fgf receptor- and Wnt-pathways contribute to increased Ffg23 gene transcription in Hyp bone. We found evidence in Hyp bone for increased expression of Fgf1, Fgf7, and Egr2 in the Fgf-signaling pathway and decrements in Sost and Cpz and increments in Sfrp1 and 4 in the Wnt-signaling pathway. Moreover, activation of Fgf and Wnt-signaling stimulated, whereas Tgf β inhibited Fgf23 promoter activity in osteoblasts. We also observed reductions in Bmp1, a metalloproteinase that metabolizes the Fgf23 regulatory extracellular matrix protein Dmp1. These findings suggest that elevation of Fgf23 expression in osteocytes is regulated by interactions between cell surface expression of Phex, extracellular matrix proteins and paracrine effects of Fgf and Wnt. Alterations were also found in enzymes regulating the posttranslational processing and stability of Fgf23, including decrements in the glycosyltransferase Galnt3 and the proprotein convertase Pcsk5. In addition, we found that the Pcsk5 and the glycosyltransferase Galnt3 were decreased in Hyp bone, suggesting that reduced post-translational processing of FGF23 may also contribute to increased Fgf23 levels in Hyp mice. With regards to mineralization, we identified additional candidates to explain the intrinsic mineralization defect in Hyp osteoblasts, including increases in the mineralization inhibitors Mgp and Thbs4, as well as increases in local pH altering factors, carbonic anhydrase 12 (Car12) and 3 (Car3) and the sodium-dependent citrate transporter (Slc13a5). These studies demonstrate the complexity of gene expression alterations in bone that accompanies inactivating Phex mutations and identify novel pathways that may coordinate Fgf23 expression and mineralization of extracellular matrix in Hyp bone. We isolated total RNAs from long bones of both WT and Hyp mice at 12 days of age. Since the RNA yields from the long bones are very low, we combined 2 bone samples with same genotype (WT or Hyp) for one RNA extraction. We will compare the difference of the gene expressions between Hyp and WT. We will use 4 samples in each animal condition.